Manufacturing

The change would impact every package and hundreds of systems.

CBM’s plasmid manufacturing offering is designed to provide phase-appropriate plasmids on demand for companies working on cell and gene therapies.

The new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in manufacturing.

Improvements to Fluid Air’s Magnaflo filter blowback system are intended to increase powder yield in PolarDry Models 001 and 004.

Webinar Date/Time: Thursday February 24, 2023 at 11am EST | 10am CST | 8am PST

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.

Efforts to optimize the delivery of sensitive biotherapeutics continue to evolve.

ROSS’ Dual Shaft Mixers can batch dispersions, suspensions, and emulsions with viscosities up to several hundred thousand centipoise.

The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.

Bio-Rad Laboratories’ EconoFit Column Packs provide resin screening for customers developing protein purification workflows.

Thermo Fisher Scientific’s QualTrak is tailored for biologics development.

Pharmapack Europe experts expect smaller and medium European packaging companies to grow or be acquired.

Webinar Date/Time: Thu, Oct 27, 2022 11:00 AM EDT

CRB’s latest industry report includes an expanded audience to include many European countries, which has provided some interesting insights.

It’s crucial to consider the optimal handling systems for cleanroom and other lab environments.

Materials enhance sustainability and efficiency.

It is intended to identify the most prevalent and immunogenic targets in solid tumors by uniquely combining high-diversity target libraries with active machine learning.

Webinar Date/Time: Tue, Jan 31, 2023 11:00 AM EST

Public relations agencies dissect pharmaceutical trends: Brandwidth Solutions, Orientation Marketing and White Matter Communications

Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.

This compilation allows readers to adjust their thinking to appreciate the full impact certain select technologies will make on the industry by 2026.

Bio/pharma has evolved and adapted to a variety of challenges in 2022, but what might be on the cards for the industry in 2023?

Cautiously setting aside pandemic practices, pharma workers appear ready for flux, change, evolution, and expanding molecular diversity.

Experts weigh in on trends in the biotechnology market, psychedelics, and India.

As the therapeutic landscape grows more complex, so too must the analytical techniques for cleaning validation to ensure the utmost cleanliness is achieved.